A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

NCT04633213 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

577

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: HBM9036 0.25% Ophthalmic Solution
DRUG: Placebo

Sponsor

Harbour BioMed (Guangzhou) Co. Ltd.